Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:01:27 2024-07-05 pm EDT 5-day change 1st Jan Change
28.05 USD +1.26% Intraday chart for Pfizer, Inc. +0.25% -2.57%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code MT
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches MT
Pfizer: former State Street CEO joins board CF
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Management CI
PFIZER INC : Berenberg gives a Neutral rating ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount MT
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling MT
Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case MT
Pfizer: new member elected to the Board of Directors CF
Vaxcyte Appoints John Furey to Board of Directors CI
US DOJ informs Viatris' Mylan is no longer part of antitrust investigation RE
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits MT
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case RE
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge RE
Vera Therapeutics Appoints David Johnson as Chief Operating Officer MT
Pfizer Inc Appoints Cyrus Taraporevala to Board of Directors, Audit Committee and Compensation Committee CI
Tiny Chain Bridge is top banker to Trump, Republican campaigns RE
Pfizer Inc.(NYSE:PFE) added to Russell 1000 Dynamic Index CI
Pfizer: CHMP recommends new Covid vaccine CF
Would you like some more inflation? Our Logo
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older RE
Pfizer Inc. and BioNTech SE Receives Positive CHMP Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in the European Union CI
Pfizer Inc.(NYSE:PFE) dropped from Russell Top 50 Index CI
Pfizer, BioNTech Get Positive Committee Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in European Union MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.05 USD
Average target price
31.92 USD
Spread / Average Target
+13.78%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Sector Update: Health Care Stocks Rise in Late Afternoon Trading